Nextrials has partnered with InClin to deliver next generation clinical research services.
As part of the partnership, researchers are expected to have the advantage of linking Nextrials' Prism, a clinical trial data management platform with InClin's personalized services to accelerate study starts and lower drug development costs.
InClin CEO Dirk Thye said, "We take pride in our ability to deliver superior data quality to our sponsors, and Nextrials' Prism meets our high standards as an enabling data management platform that can significantly shorten the length of time it takes to initiate and monitor a clinical trial."
Prism, its design tools and its new iPad interface, give pharmaceutical and biotech researchers anytime/anywhere access to key data points, reports and statistics about ongoing studies regardless of location.
It also enables sponsors to better manage investigator site data and gives access to data related to patient demographics, recruitment/enrollment status, queries and more.
Nextrials CEO and co-founder James Rogersn said,""Prism's capabilities, combined with InClin's senior project management team and its standardized performance indicators and quality metrics processes, give sponsors an edge in obtaining critical study data on a timely basis and keeping studies on track."
